Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01377688 · ClinicalTrials.gov registry record
Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 19
- Enrollment target
NCT01377688: Completed study, sponsored by Duke University.
NCT01377688 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01377688 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
We propose to pilot a telehealth approach to evaluate components of risk communication by: 1. Providing personalized tailored patient feedback to help initiate and maintain specific diabetic kidney disease (DKD)-related behaviors (e.g., medication adherence, weight, exercise, diet, smoking cessation) to reduce their risks. 2. Evaluating how this feedback can be incorporated into clinical care by examining 6 month patient outcomes. Specific Aims are: 1. To evaluate the feasibility and acceptability of providing both patients and their provider feedback on individuals' DKD risk via the telehealth intervention and incorporating it into regular clinical practice. 2. If improvements in outcomes are found, to estimate the cost of the program in terms of the patient, provider, and overall costs of implementing the program.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-05 |
What the finished NCT01377688 record still lists
NCT01377688 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01377688 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01377688 about?
NCT01377688 is a clinical study titled "Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes". We propose to pilot a telehealth approach to evaluate components of risk communication by: 1. Providing personalized tailored patient feedback to help initiate and maintain specific diabetic kidney disease (DKD)-related behaviors (e.g., medication adherence, weight, exercise, diet, smoking cessatio...
What is the current status of trial NCT01377688?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2011-10. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT01377688?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia